journal article·2011-09-27

The Evolution of the Protein Corona around Nanoparticles: A Test Study

Martin Lundqvist, Johannes Stigler, Tommy Cedervall, Tord Berggård, Michelle B. Flanagan, Iseult Lynch, Giuliano Elia, Kenneth Dawson

ACS Nano· Volume 5· Issue 9
Publisher page

Abstract

The importance of the protein corona formed around nanoparticles upon entering a biological fluid has recently been highlighted. This corona is, when sufficiently long-lived, thought to govern the particles' biological fate. However, even this long-lived "hard" corona evolves and re-equilibrates as particles pass from one biological fluid to another, and may be an important feature for long-term fate. Here we show the evolution of the protein corona as a result of transfer of nanoparticles from one biological fluid (plasma) into another (cytosolic fluid), a simple illustrative model for the uptake of nanoparticles into cells. While no direct comparison can be made to what would happen in, for example, the uptake pathway, the results confirm that significant evolution of the corona occurs in the second biological solution, but that the final corona contains a "fingerprint" of its history. This could be evolved to map the transport pathways utilized by nanoparticles, and eventually to predict nanoparticle fate and behavior.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanoparticle-Based Drug Delivery · Protein Interaction Studies and Fluorescence Analysis · Polymer Surface Interaction Studies

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Centre for BioNano Interactions, School of Chemistry and Chemical Biology, University College Dublin, Dublin, Ireland

Center for Molecular Protein Science, Biochemistry, Lund University, Lund, Sweden

Alligator Bioscience AB, Lund, Sweden

Conway Institute, University College Dublin, Dublin, Ireland

Mass Spectrometry Resource, Conway Institute, University College Dublin, Dublin, Ireland

References (30)

Show source-provided references
1. Lundqvist M. · Proc. Natl. Acad. Sci. U.S.A. · 2008 · 105 · 1426510.1073/pnas.0805135105 ↗
2. Lynch I. · Nano Today · 2008 · 3 · 4010.1016/S1748-0132(08)70014-8 ↗
3. Hellstrand E. · FEBS J. · 2009 · 276 · 337210.1111/j.1742-4658.2009.07062.x ↗
4. Cedervall T. · Angew. Chem., Int. Ed. · 2007 · 46 · 575410.1002/anie.200700465 ↗
5. Cedervall T. · Proc. Natl. Acad. Sci. U.S.A. · 2007 · 104 · 205010.1073/pnas.0608582104 ↗
6. Clift M. J. D. · Toxicol. Lett. · 2010 · 198 · 35810.1016/j.toxlet.2010.08.002 ↗
7. Maiorano G. · ACS Nano · 2010 · 4 · 748110.1021/nn101557e ↗
8. Xia X. R. · Nat. Nanotech · 2010 · 5 · 67110.1038/nnano.2010.164 ↗
9. Dell’Orco D. · Plos One · 2010 · 5 · e1094910.1371/journal.pone.0010949 ↗
10. Casals E. · ACS Nano · 2010 · 4 · 362310.1021/nn901372t ↗
11. Lynch I. · Sci. STKE · 2006 · 327 · pe14
12. Abramoff M. D. · Biophotonics Int. · 2004 · 11 · 36
13. Allémann E. · J. Biomed. Mater. Res. · 1997 · 37 · 22910.1002/(SICI)1097-4636(199711)37:2<229::AID-JBM12>3.0.CO;2-9 ↗
14. Blunk T. · Electrophoresis · 1993 · 14 · 138210.1002/elps.11501401214 ↗
15. Diederichs J. E. · Electrophoresis · 1996 · 17 · 60710.1002/elps.1150170332 ↗
16. Gessner A. · Eur. J. Pharm. Biopharm. · 2002 · 54 · 16510.1016/S0939-6411(02)00081-4 ↗
17. Gessner A. · J. Biomed. Mater. Res. A · 2003 · 65 · 31910.1002/jbm.a.10371 ↗
18. Gessner A. · Int. J. Pharm. · 2000 · 196 · 24510.1016/S0378-5173(99)00432-9 ↗
19. Gref R. · Colloids Surf. B · 2000 · 18 · 30110.1016/S0927-7765(99)00156-3 ↗
20. Göppert T. M. · J. Drug Targeting · 2003 · 11 · 22510.1080/10611860310001615956 ↗
21. Göppert T. M. · J. Drug Targeting · 2005 · 13 · 17910.1080/10611860500071292 ↗
22. Göppert T. M. · Int. J. Pharm. · 2005 · 302 · 17210.1016/j.ijpharm.2005.06.025 ↗
23. Labarre D. · Biomaterials · 2005 · 26 · 507510.1016/j.biomaterials.2005.01.019 ↗
24. Lück M. · J. Biomed. Mater. Res. · 1998 · 39 · 47810.1002/(SICI)1097-4636(19980305)39:3<478::AID-JBM19>3.0.CO;2-6 ↗
25. Müller R. H. · Pharm. Res. · 1997 · 14 · 1810.1023/A:1012043131081 ↗
26. Salvador-Morales C. · Mol. Immunol. · 2006 · 43 · 19310.1016/j.molimm.2005.02.006 ↗
27. Thode K. · Pharm. Res. · 1997 · 14 · 90510.1023/A:1012104017761 ↗
28. Shevchenko A. · Anal. Chem. · 1996 · 68 · 85010.1021/ac950914h ↗
29. Yates J. R. · Anal. Chem. · 1995 · 67 · 142610.1021/ac00104a020 ↗
30. Berggård T. · J. Proteome Res. · 2006 · 5 · 66910.1021/pr050421l ↗